ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women

Marcuello, 2013, Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the diabetes study, Acta Diabetol, 50, 615, 10.1007/s00592-013-0468-8 2001, Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III), JAMA, 285, 2486e2489 Ford, 2004, Increasing prevalence of the metabolic syndrome among U.S. adults, Diabetes Care, 27, 2444, 10.2337/diacare.27.10.2444 Manson, 2015, Biomarkers of cardiovascular disease risk in women, Metabolism, 64, S33, 10.1016/j.metabol.2014.10.028 Libby, 2013, Mechanisms of acute coronary syndromes and their implications for therapy, N Engl J Med, 368, 2004, 10.1056/NEJMra1216063 Xu, 2012, The relationship between high-sensitivity C-reactive protein and ApoB, ApoB/ApoA1 ratio in general population of China, Endocrine, 42, 132, 10.1007/s12020-012-9599-x Heres Álvarez, 2011, Proteína C reactiva y enfermedad arterial coronaria, Rev Cubana Cardiol Cir Cardiovasc, 17, 69 Ahn, 2016, High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training, Integr Med Res, 5, 212, 10.1016/j.imr.2016.07.001 Mangaraj, 2016, Apolipoprotein A-I: a molecule of diverse function, Indian J Clin Biochem, 31, 253, 10.1007/s12291-015-0513-1 Jung, 2012, The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population, Clin Endocrinol (Oxf), 77, 699, 10.1111/j.1365-2265.2012.04329.x Shapiro, 2017, Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease [version 1; referees: 2 approved], F1000 Res, 6, 134, 10.12688/f1000research.9845.1 Walldius, 2006, The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy – a review of the evidence, J Intern Med, 259, 493, 10.1111/j.1365-2796.2006.01643.x Mao, 2017, The nonlinear association between apolipoprotein B to apolipoprotein A1 ratio and type 2 diabetes, Medicine (Baltimore), 96, e5834, 10.1097/MD.0000000000005834 Hwang, 2012, Increased apoB/A-I ratio independently associated with type 2 diabetes mellitus: cross-sectional study in a Korean population, Diabet Med, 29, 1165, 10.1111/j.1464-5491.2012.03622.x Sierra-Johnson, 2007, ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects, Eur Heart J, 28, 2637, 10.1093/eurheartj/ehm360 Du, 2014, Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance, Cardiovasc Diabetol, 13, 146, 10.1186/s12933-014-0146-3 Walldius, 2001, High apolipoprotein B, low apolipoprotein A1, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study, Lancet, 358, 2026, 10.1016/S0140-6736(01)07098-2 Jing, 2014, The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study, Lipids Health Dis, 10.1186/1476-511X-13-81 Kim, 2013, Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1, Int J Cardiol, 168, 2678, 10.1016/j.ijcard.2013.03.027 Inzucchi, 2015, ADA/European Association for the Study of Diabetes (EASD) position statement on management of hyperglycemia in type 2 diabetes, Diabetes Care, 38, 140, 10.2337/dc14-2441 https://www.healthcare.siemens.com/immunoassay/systems/adviacentaur-xp. https://www.healthcare.siemens.com/integratedchemistry/systems/dimension-vista-1500-intel-lab-sys/assays. http://www-01.ibm.com/support/docview.wss?uid=swg24034354. Rye, 2016, Apolipoprotein A-I interactions with insulin secretion and production, Curr Opin Lipidol, 27, 8, 10.1097/MOL.0000000000000253 Onat, 2010, The paradox of high apolipoprotein A-I levels independently predicting incident type-2 diabetes among Turks, Int J Cardiol, 142, 72, 10.1016/j.ijcard.2008.12.066 Sathvika, 2013, Assessment of insulin resistance and ApoB/ApoA1 ratio in type II diabetes patients, Natl J Basic Med Sci, vol. III Walldius, 2012 Liting, 2015, Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients, Herz, 40, 1, 10.1007/s00059-014-4147-5 Savas, 2010, Utility of ApoB/ApoA1 ratio for the prediction of cardiovascular risk in children with metabolic syndrome, Indian J Pediatr, 77, 1261, 10.1007/s12098-010-0217-8 Arsenault, 2010, Lipid assessment, metabolic syndrome and coronary heart disease risk, Eur J Clin Invest, 40, 1081, 10.1111/j.1365-2362.2010.02357.x Wallenfeldt, 2004, Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men, Stroke, 35, 2248, 10.1161/01.STR.0000140629.65145.3c Zhong, 2010, The ApoB/ApoA1 ratio is associated with metabolic syndrome and its components in a Chinese population, Inflammation, 33, 353, 10.1007/s10753-010-9193-4 Wilsgaard, 2015, Clinically significant novel biomarkers for prediction of first ever myocardial infarction: the Tromsø study, Circ Cardiovasc Genet, 8, 363, 10.1161/CIRCGENETICS.113.000630 Gianfagna, 2014, Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study, Atherosclerosis, 236, 175, 10.1016/j.atherosclerosis.2014.06.029 Vijayvergiya, 2017, Analysis of traditional and emerging risk factors in premenopausal women with coronary artery disease: a pilot-scale study from North India, Mol Cell Biochem, 432, 67, 10.1007/s11010-017-2998-9 Bodde, 2018, Apolipoproteins A1 B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up, Clin Res Cardiol Schmidt, 2014, Apolipoprotein B/Apolipoprotein A-I ratio and apolipoprotein B long-term predictors of myocardial infarction in initially healthy middle-aged men—a 13-year follow-up, Angiology, 65, 901, 10.1177/0003319713511849 Glasziou, 2014, Which lipid measurement should we monitor? An analysis of the LIPID study, BMJ Open, 4, e003512, 10.1136/bmjopen-2013-003512 Carnevale Schianca, 2011, ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk, Nutr Metab Cardiovasc Dis, 21, 406, 10.1016/j.numecd.2009.11.002 Kaneva, 2015, The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity, Dis Mark, 2015, 591454